Nine MIT researchers, including two affiliated with IMES, are selected as finalists for 2021 prize supported by Northpond Ventures; grand prize winner to receive $250K toward commercializing her human health-related invention. In a fitting sequel to its entrepreneurship “boot camp” educational lecture series last fall, the MIT Future Founders Initiative…

​Covid-19 has been a reminder of the need to better understand infectious diseases, and the oversized impact on historically marginalized communities. The ongoing COVID-19 pandemic has been a stark reminder of the global impact of infectious diseases, and the grave necessity for medical science to better understand how to detect,…

Collaborators, including an IMES faculty member, investigate colon health with novel tools In a building at the edge of the Massachusetts General Hospital (MGH) complex, Ömer Yilmaz, MD, and a group of pathology residents gather around a microscope. A resident reads from a chart: a growth was found in the…

The prevalence of auditory symptoms in Covid-19 patients is unknown, but infection of the inner ears may be responsible for hearing and balance problems. Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus…

A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases. Researchers at MIT, including at IMES, and Harvard University, have designed a way to selectively turn on gene therapies in target cells, including human cells. Their technology can detect specific…